
Daito Pharmaceutical Co Ltd
TSE:4577

Daito Pharmaceutical Co Ltd
Research & Development
Daito Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Daito Pharmaceutical Co Ltd
TSE:4577
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Research & Development
-ÂĄ710.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
![]() |
Daiichi Sankyo Co Ltd
TSE:4568
|
Research & Development
-ÂĄ410.8B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-30%
|
|
![]() |
Otsuka Holdings Co Ltd
TSE:4578
|
Research & Development
-ÂĄ314.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-2%
|
|
![]() |
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Research & Development
-ÂĄ181.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
|
![]() |
Astellas Pharma Inc
TSE:4503
|
Research & Development
-ÂĄ329.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-5%
|
Daito Pharmaceutical Co Ltd
Glance View
Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
